Home > NRC Library > ADAMS Public Documents

Forwards "Abbreviated Summary of Approved Radiopharm Drug Products," dtd 810401 per 860327 request re Glofil-125. Licensees authorized for Groups I & II may use Glofil-125 as Group I procedure but not as Group II procedure.W/o encl.

Accession Number: ML20205C889

Date Released: Tuesday, October 29, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20205C882 - Forwards "Abbreviated Summary of Approved Radiopharm Drug Products," dtd 810401 per 860327 request re Glofil-125. Licensees authorized for Groups I & II may use Glofil-125 as Group I procedure but not as Group II procedure.W/o encl. (1 page(s), 8/1/1986)
• ML20205C892 - Requests written confirmation that I-125 iothalamate (Glofil) can be used by licensees authorized for Groups I or II to monitor glomerular filtration rate,per 860325 telcon. (1 page(s), 3/27/1986)